TapewireFind a company

person · Reporting owner

Landy Mark

Disclosed activity across 1 company

Tapewire entity
155802
SEC CIK
0001364726

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MIMEDX GROUP, INC.MDXG · Entity 5271EVP & Chief Strategy OfficerJuly 25, 2019July 29, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MIMEDX GROUP, INC.

Report date July 25, 2019 · Filed July 29, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect379,925 Ending reported balance After 2019-07-26 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2019-07-25 · Tax withholding · Disposed 2,809 · Balance 380,527

F1: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

Row 2 · 2019-07-26 · Tax withholding · Disposed 602 · Balance 379,925

F1: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 26, 2019 Filed Jul 29, 2019 19:45 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 Tax withholdingCommon Stock 602 $5.35 $3,217.69
Disclosure

SEC source: 0001376339-19-000032 · wf-form4_156442953386749.xml · nonDerivative · entry 2

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379,925

F1 · kind: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

Read SEC document
July 25, 2019 Filed Jul 29, 2019 19:45 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 Tax withholdingCommon Stock 2,809 $5.15 $14,466.35
Disclosure

SEC source: 0001376339-19-000032 · wf-form4_156442953386749.xml · nonDerivative · entry 1

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,527

F1 · kind: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

Read SEC document
April 26, 2019 Filed Apr 30, 2019 21:01 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 GrantCommon Stock 175,000 $2.41 $421,750.00
Disclosure

SEC source: 0001376339-19-000016 · wf-form4_155665808833491.xml · nonDerivative · entry 2

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 383,336

F2 · kind: Represents special retention grant of restricted stock which vests one-third on each anniversary.

Read SEC document
April 26, 2019 Filed Apr 30, 2019 21:01 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 GrantCommon Stock 104,271 $2.41 $251,293.11
Disclosure

SEC source: 0001376339-19-000016 · wf-form4_155665808833491.xml · nonDerivative · entry 1

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,336

F1 · kind: Represents annual grant of restricted stock which vests one-third on each anniversary.

Read SEC document
February 22, 2019 Filed Feb 25, 2019 21:21 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 Tax withholdingCommon Stock 2,041 $3.15 $6,429.15
Disclosure

SEC source: 0001376339-19-000011 · wf-form4_155112969836748.xml · nonDerivative · entry 2

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,065

F1 · shares: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

Read SEC document
February 22, 2019 Filed Feb 25, 2019 21:21 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 Tax withholdingCommon Stock 2,949 $3.15 $9,289.35
Disclosure

SEC source: 0001376339-19-000011 · wf-form4_155112969836748.xml · nonDerivative · entry 1

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,106

F1 · shares: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 14:18 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 Tax withholdingCommon Stock 708 $1.55 $1,097.40
Disclosure

SEC source: 0001376339-18-000050 · wf-form4_154514266406998.xml · nonDerivative · entry 1

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,055

F1 · kind: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 21:58 UTC Amendment MIMEDX GROUP, INC. MDXG · Entity 5271 GrantCommon Stock 30,000 $1.54 $46,200.00
Disclosure

SEC source: 0001364726-18-000007 · wf-form4a_154473830055711.xml · nonDerivative · entry 1

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,763

F1 · shares: This amendment is filed to correct the number of shares acquired.

F2 · balance_after: Includes 86,968 shares of unvested restricted stock.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 21:35 UTC MIMEDX GROUP, INC. MDXG · Entity 5271 GrantCommon Stock 0 $1.54 $0.00
Disclosure

SEC source: 0001364726-18-000005 · wf-form4_154473689461536.xml · nonDerivative · entry 1

Landy Mark · CIK 0001364726 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,763

F1 · balance_after: Includes 86,968 shares of unvested restricted stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.